Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Viguera

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Psychiatry|December 29, 2007
Treatment of premenstrual worsening of depression with adjunctive oral contraceptive pills: a preliminary reportHadine Joffe, Laura F Petrillo, Adele C Viguera, et al.
Archives of Women'S Mental Health|July 28, 2021
Breastfeeding practices among women taking second-generation antipsychotics: findings from the National Pregnancy Registry for Atypical AntipsychoticsAdele C Viguera, Rachel Vanderkruik, Peter Gaccione, et al.
The American Journal of Medicine|February 12, 2008
Paroxetine versus placebo for women in midlife after hormone therapy discontinuationClaudio N Soares, Hadine Joffe, Adele C Viguera, et al.
Psychosomatics|August 18, 2015
Comparison of Electronic Screening for Suicidal Risk With the Patient Health Questionnaire Item 9 and the Columbia Suicide Severity Rating Scale in an Outpatient Psychiatric ClinicAdele C Viguera, Nicholas Milano, Ralston Laurel, et al.
The American Journal of Psychiatry|December 7, 2007
Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuationAdele C Viguera, Theodore Whitfield, Ross J Baldessarini, et al.
Journal of Psychiatric Research|August 16, 2017
Use of atypical antipsychotics in pregnancy and maternal gestational diabetesAlice Panchaud, Sonia Hernandez-Diaz, Marlene P Freeman, et al.
The Journal of Clinical Psychiatry|March 15, 2024
Effects of Prenatal Exposure to Second-Generation Antipsychotics on Development and Behavior Among Preschool-Aged Children: Preliminary Results From the National Pregnancy Registry for Psychiatric MedicationsCarol Swetlik, Lee S Cohen, Lauren A Kobylski, et al.
General Hospital Psychiatry|September 15, 2022
Risk for postpartum depressive symptoms among pregnant women in a tertiary care setting with and without a positive COVID-19 testKatherine E Taljan, Ashley Cantu-Weinstein, Madeline McKenna, et al.
The Journal of Clinical Psychiatry|June 27, 2007
Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetineHadine Joffe, Claudio N Soares, Laura F Petrillo, et al.
The Journal of Clinical Psychiatry|September 20, 2001
Venlafaxine in the treatment of postpartum depressionL S Cohen, A C Viguera, S M Bouffard, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Psychiatry|December 29, 2007
Treatment of premenstrual worsening of depression with adjunctive oral contraceptive pills: a preliminary reportHadine Joffe, Laura F Petrillo, Adele C Viguera, et al.
Archives of Women'S Mental Health|July 28, 2021
Breastfeeding practices among women taking second-generation antipsychotics: findings from the National Pregnancy Registry for Atypical AntipsychoticsAdele C Viguera, Rachel Vanderkruik, Peter Gaccione, et al.
The American Journal of Medicine|February 12, 2008
Paroxetine versus placebo for women in midlife after hormone therapy discontinuationClaudio N Soares, Hadine Joffe, Adele C Viguera, et al.
Psychosomatics|August 18, 2015
Comparison of Electronic Screening for Suicidal Risk With the Patient Health Questionnaire Item 9 and the Columbia Suicide Severity Rating Scale in an Outpatient Psychiatric ClinicAdele C Viguera, Nicholas Milano, Ralston Laurel, et al.
The American Journal of Psychiatry|December 7, 2007
Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuationAdele C Viguera, Theodore Whitfield, Ross J Baldessarini, et al.
Journal of Psychiatric Research|August 16, 2017
Use of atypical antipsychotics in pregnancy and maternal gestational diabetesAlice Panchaud, Sonia Hernandez-Diaz, Marlene P Freeman, et al.
The Journal of Clinical Psychiatry|March 15, 2024
Effects of Prenatal Exposure to Second-Generation Antipsychotics on Development and Behavior Among Preschool-Aged Children: Preliminary Results From the National Pregnancy Registry for Psychiatric MedicationsCarol Swetlik, Lee S Cohen, Lauren A Kobylski, et al.
General Hospital Psychiatry|September 15, 2022
Risk for postpartum depressive symptoms among pregnant women in a tertiary care setting with and without a positive COVID-19 testKatherine E Taljan, Ashley Cantu-Weinstein, Madeline McKenna, et al.
The Journal of Clinical Psychiatry|June 27, 2007
Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetineHadine Joffe, Claudio N Soares, Laura F Petrillo, et al.
The Journal of Clinical Psychiatry|September 20, 2001
Venlafaxine in the treatment of postpartum depressionL S Cohen, A C Viguera, S M Bouffard, et al.
Pageof 10